Multisystem Inflammatory Syndrome in Adults Associated with Recent Infection with COVID-19
Multisystem inflammatory syndrome in adults (MIS-A) is an uncommon but severe and still understudied post-infectious complication of COVID-19. Clinically, the disease manifests itself most often 2–6 weeks after overcoming the infection. Young and middle-aged patients are especially affected. The cli...
Main Authors: | Ondrej Zahornacky, Štefan Porubčin, Alena Rovnakova, Pavol Jarcuska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/13/5/983 |
Similar Items
-
Children’s Multisystem inflammatory syndrome with myopathy
by: Zina Maria Almeida de Azevedo, et al.
Published: (2021-03-01) -
Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review
by: Nicole Atchessi, et al.
Published: (2021-07-01) -
Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
by: Istemi Serin, et al.
Published: (2022-03-01) -
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland
by: Luregn J. Schlapbach, et al.
Published: (2021-05-01) -
Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents
by: Audrey Dionne, et al.
Published: (2022-10-01)